-
3-{5-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]pentanamido}-2,4,6-triiodobenzoic acid
-
ChemBase ID:
4263
-
Molecular Formular:
C20H14I6N2O6
-
Molecular Mass:
1139.76178
-
Monoisotopic Mass:
1139.51202418
-
SMILES and InChIs
SMILES:
Ic1c(NC(=O)CCCCC(=O)Nc2c(I)c(c(I)cc2I)C(=O)O)c(I)cc(I)c1C(=O)O
Canonical SMILES:
O=C(Nc1c(I)cc(c(c1I)C(=O)O)I)CCCCC(=O)Nc1c(I)cc(c(c1I)C(=O)O)I
InChI:
InChI=1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34)
InChIKey:
FFINMCNLQNTKLU-UHFFFAOYSA-N
-
Cite this record
CBID:4263 http://www.chembase.cn/molecule-4263.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3-{5-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]pentanamido}-2,4,6-triiodobenzoic acid
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Transbilix
|
Cholospect
|
Cholografin
|
Biligrafin
|
Bilignostum
|
Bilignost
|
|
|
Synonyms
|
Iodipamide
|
3,3'-[(1,6-dioxohexane-1,6-diyl)diimino]bis(2,4,6-triiodobenzoic acid)
|
Iodipamic acid
|
Adipiodone
|
Adipiodonum [INN-Latin]
|
Adipiodona [INN-Spanish]
|
IDB
|
Iodipamide
|
3,3'-[(1,6-Dioxo-1,6-hexanediyl)diimino]bis[2,4,6-triiodobenzoic Acid
|
3,3'-(Adipoyldiimino)-bis(2,4,6-triiodobenzoic Acid)
|
Adipic Acid Bis(3-carboxy-2,4,6-triiodoanilide)
|
Cholografin
|
Cholospect
|
3,3′-(己二酰二亚氨基)双(2,4,6-三碘苯甲酸)
|
胆影酸
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
2.0255375
|
H Acceptors
|
6
|
H Donor
|
4
|
LogD (pH = 5.5)
|
2.217679
|
LogD (pH = 7.4)
|
1.2136091
|
Log P
|
8.248091
|
Molar Refractivity
|
183.981 cm3
|
Polarizability
|
70.95157 Å3
|
Polar Surface Area
|
132.8 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
false
|
Log P
|
3.42
|
LOG S
|
-5.57
|
Solubility (Water)
|
3.06e-03 g/l
|
DETAILS
DETAILS
DrugBank
TRC
DrugBank -
DB04711
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Iodipamide is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography. [PubChem] |
Indication |
Iodipamide is used as a contrast agent for cholecystography and intravenous cholangiography. |
Toxicity |
Ionic radiocontrast agents like iodipamide are cytotoxic to renal cells. The toxic effects include apoptosis, cellular energy failure, disruption of calcium homeostasis, and disturbance of tubular cell polarity, and are thought to be linked to oxidative stress. Acute IV LD50 is 5000 mg/kg in rat, 3195 mg/kg in mouse, and 1200 mg/kg in dog.
|
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic.
|
References |
• |
Lin SK, Moss AA, Riegelman S: Iodipamide kinetics: capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion. J Pharm Sci. 1977 Dec;66(12):1670-4.
[Pubmed]
|
|
|
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Lin SK, Moss AA, Riegelman S: Iodipamide kinetics: capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion. J Pharm Sci. 1977 Dec;66(12):1670-4. Pubmed
- • Kiyano, et al.: Radioisotopes, 20, 78 (1971)
- • Lerner, H.H., et al.: Anal. Profiles Drug Subs., 3, 333 (1971)
- • Rosenberg, F.J., et al.: Invest. Radiol., 15, S142 (1971)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent